Pasithea Therapeutics Corp. - 8-K Filing
Pasithea Therapeutics approved a reverse stock split and elected two directors at its annual meeting on September 9, 2026. (Items: 5.07 Submission of Matters to a Vote of Security Holders, 9.01 Financial Statements and Exhibits)
Tickers: $KTTA